PIP2-Effector Protein MPRIP Regulates RNA Polymerase II Condensation and Transcription

Biomolecules. 2023 Feb 24;13(3):426. doi: 10.3390/biom13030426.

Abstract

The specific post-translational modifications of the C-terminal domain (CTD) of the Rpb1 subunit of RNA polymerase II (RNAPII) correlate with different stages of transcription. The phosphorylation of the Ser5 residues of this domain associates with the initiation condensates, which are formed through liquid-liquid phase separation (LLPS). The subsequent Tyr1 phosphorylation of the CTD peaks at the promoter-proximal region and is involved in the pause-release of RNAPII. By implementing super-resolution microscopy techniques, we previously reported that the nuclear Phosphatidylinositol 4,5-bisphosphate (PIP2) associates with the Ser5-phosphorylated-RNAPII complex and facilitates the RNAPII transcription. In this study, we identified Myosin Phosphatase Rho-Interacting Protein (MPRIP) as a novel regulator of the RNAPII transcription that recruits Tyr1-phosphorylated CTD (Tyr1P-CTD) to nuclear PIP2-containing structures. The depletion of MPRIP increases the number of the initiation condensates, indicating a defect in the transcription. We hypothesize that MPRIP regulates the condensation and transcription through affecting the association of the RNAPII complex with nuclear PIP2-rich structures. The identification of Tyr1P-CTD as an interactor of PIP2 and MPRIP further points to a regulatory role in RNAPII pause-release, where the susceptibility of the transcriptional complex to leave the initiation condensate depends on its association with nuclear PIP2-rich structures. Moreover, the N-terminal domain of MPRIP, which is responsible for the interaction with the Tyr1P-CTD, contains an F-actin binding region that offers an explanation of how nuclear F-actin formations can affect the RNAPII transcription and condensation. Overall, our findings shed light on the role of PIP2 in RNAPII transcription through identifying the F-actin binding protein MPRIP as a transcription regulator and a determinant of the condensation of RNAPII.

Keywords: MPRIP; PIP2; RNA polymerase II; phase separation; transcription.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Actins* / metabolism
  • Humans
  • Myosin-Light-Chain Phosphatase / genetics
  • Myosin-Light-Chain Phosphatase / metabolism
  • Phosphoprotein Phosphatases / genetics
  • Phosphorylation
  • RNA Polymerase II* / chemistry
  • Transcription, Genetic

Substances

  • Actins
  • Myosin-Light-Chain Phosphatase
  • Phosphoprotein Phosphatases
  • RNA Polymerase II
  • MPRIP protein, human

Grants and funding

This work was supported by the Grant Agency of the Czech Republic (Grant nos. 19-05608S and 18-19714S); by the Czech Academy of Sciences (Grant no. JSPS-20-06); by the Institutional Research Concept of the Institute of Molecular Genetics (Grant no. RVO: 68378050); by the MEYS CR (COST Inter-Excellence Internship LTC19048 and LTC20024) and the project: “BIOCEV—Biotechnology and Biomedicine Centre of the Academy of Sciences and Charles University” (CZ.1.05/1.1.00/02.0109), from the European Regional Development Fund. COST Pan-European Network in Lipidomics and Epilipidomics (EpiLipidNET CA19105 action). The Microscopy Centre was supported by the MEYS CR (LM2018129 Czech-BioImaging) and by the European Regional Development Fund—Project “Modernization and support of research activities of the national infrastructure for biological and medical imaging CzechBioImaging” (no. CZ.02.1.01/0.0/0.0/16_013/0001775).